blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2146989

EP2146989 - TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.11.2012
Database last updated on 26.07.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
LEO PHARMA A/S
Industriparken 55
2750 Ballerup / DK
[2010/04]
Inventor(s)01 / FELDING, Jakob
Ordrupho̸jvej 29, 1
DK-2920 Charlottenlund / DK
02 / SO̸RENSEN, Morten, Dahl
Bomlærkevej 15
DK-2970 Ho̸rsholm / DK
 [2010/04]
Representative(s)Thalsoe-Madsen, Kine Birgit, et al
Leo Pharma A/S
Industriparken 55
2750 Ballerup / DK
[N/P]
Former [2010/04]Thalsoe-Madsen, Kine Birgit, et al
Leo Pharma A/S, Industriparken 55
2750 Ballerup / DK
Application number, filing date08758202.916.04.2008
[2010/04]
WO2008DK00135
Priority number, dateUS20070912020P16.04.2007         Original published format: US 912020 P
[2010/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008125111
Date:23.10.2008
Language:EN
[2008/43]
Type: A1 Application with search report 
No.:EP2146989
Date:27.01.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 23.10.2008 takes the place of the publication of the European patent application.
[2010/04]
Type: B1 Patent specification 
No.:EP2146989
Date:04.01.2012
Language:EN
[2012/01]
Search report(s)International search report - published on:EP23.10.2008
ClassificationIPC:C07D471/04, A61K31/53, A61P17/00
[2010/04]
CPC:
C07D471/04 (EP,US); A61P17/00 (EP); A61P17/02 (EP);
A61P17/06 (EP); A61P17/08 (EP); A61P17/10 (EP);
A61P17/14 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61K31/437 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/04]
Extension statesAL16.11.2009
BA16.11.2009
MK16.11.2009
RS16.11.2009
TitleGerman:TRIAZOLOPYRIDINE ALS PHOSPHODIESTERASEHEMMER ZUR BEHANDLUNG VON HAUTKRANKHEITEN[2010/04]
English:TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES[2010/04]
French:TRIAZOLOPYRIDINES COMME INHIBITEURS DE PHOSPHODIESTÉRASES POUR LE TRAITEMENT DE MALADIES DERMIQUES[2010/04]
Entry into regional phase16.11.2009National basic fee paid 
16.11.2009Designation fee(s) paid 
16.11.2009Examination fee paid 
Examination procedure16.11.2009Examination requested  [2010/04]
19.11.2010Despatch of a communication from the examining division (Time limit: M02)
12.01.2011Reply to a communication from the examining division
15.07.2011Communication of intention to grant the patent
10.11.2011Fee for grant paid
10.11.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.11.2010
Opposition(s)05.10.2012No opposition filed within time limit [2012/50]
Fees paidRenewal fee
26.04.2010Renewal fee patent year 03
25.04.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.04.2008
BE04.01.2012
CY04.01.2012
CZ04.01.2012
DK04.01.2012
EE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
MT04.01.2012
PL04.01.2012
RO04.01.2012
SI04.01.2012
SK04.01.2012
TR04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
LU16.04.2012
MC30.04.2012
IS04.05.2012
PT04.05.2012
[2014/34]
Former [2014/27]BE04.01.2012
CY04.01.2012
CZ04.01.2012
DK04.01.2012
EE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
MT04.01.2012
PL04.01.2012
RO04.01.2012
SI04.01.2012
SK04.01.2012
TR04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
LU16.04.2012
MC30.04.2012
IS04.05.2012
PT04.05.2012
Former [2014/21]BE04.01.2012
CY04.01.2012
CZ04.01.2012
DK04.01.2012
EE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
MT04.01.2012
PL04.01.2012
RO04.01.2012
SI04.01.2012
SK04.01.2012
TR04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
MC30.04.2012
IS04.05.2012
PT04.05.2012
Former [2013/35]BE04.01.2012
CY04.01.2012
CZ04.01.2012
DK04.01.2012
EE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
MT04.01.2012
PL04.01.2012
RO04.01.2012
SI04.01.2012
SK04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
MC30.04.2012
IS04.05.2012
PT04.05.2012
Former [2012/50]BE04.01.2012
CY04.01.2012
CZ04.01.2012
DK04.01.2012
EE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
PL04.01.2012
RO04.01.2012
SI04.01.2012
SK04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
MC30.04.2012
IS04.05.2012
PT04.05.2012
Former [2012/49]BE04.01.2012
CY04.01.2012
CZ04.01.2012
DK04.01.2012
EE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
PL04.01.2012
RO04.01.2012
SI04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
IS04.05.2012
PT04.05.2012
Former [2012/48]BE04.01.2012
CY04.01.2012
EE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
PL04.01.2012
SI04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
IS04.05.2012
PT04.05.2012
Former [2012/41]BE04.01.2012
CY04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
PL04.01.2012
SI04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
IS04.05.2012
PT04.05.2012
Former [2012/39]BE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
LV04.01.2012
PL04.01.2012
SI04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
IS04.05.2012
PT04.05.2012
Former [2012/37]BE04.01.2012
FI04.01.2012
HR04.01.2012
LT04.01.2012
PL04.01.2012
SI04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
IS04.05.2012
PT04.05.2012
Former [2012/36]BE04.01.2012
HR04.01.2012
LT04.01.2012
SI04.01.2012
BG04.04.2012
NO04.04.2012
GR05.04.2012
IS04.05.2012
Former [2012/35]BE04.01.2012
LT04.01.2012
SI04.01.2012
BG04.04.2012
NO04.04.2012
IS04.05.2012
Former [2012/34]BE04.01.2012
LT04.01.2012
SI04.01.2012
NO04.04.2012
IS04.05.2012
Former [2012/25]SI04.01.2012
Cited inInternational search[A]WO2004072072  (PFIZER PROD INC [US], et al) [A] 1-22,1-22,1-22 * the whole document * * the whole document * * the whole document *;
 [A]WO2006038116  (WARNER LAMBERT CO [US], et al) [A] 1-22,1-22,1-22 * examples 39,41,44,45,50,74,75,87 * * examples 39,41,44,45,50,74,75,87 ** examples 39,41,44,45,50,74,75,87 *;
 [A]  - BRODBECK B ET AL, "Parallel iterative solution-phase synthesis of 5-amino-1-aryl-[1,2,4]triazolo[1,5-a]pyridine-7-carboxylic acid amide derivatives", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, (20030217), vol. 44, no. 8, ISSN 0040-4039, pages 1675 - 1678, XP004405299 [A] 1-22,1-22,1-22 * the whole document * * the whole document * * the whole document *

DOI:   http://dx.doi.org/10.1016/S0040-4039(03)00062-5
by applicantEP0771794
 EP0943613
    - Z. HUANG; J.A. MANCINI, CURRENT MED. CHEM., (2006), vol. 13, pages 3253 - 3262
    - M.D. HOUSLAY ET AL., DRUG DISCOVERY TODAY, (2005), vol. 10, no. 22, pages 1503 - 1519
    - JOURNAL OF INVESTIGATIVE DERMATOLOGY, (1986), vol. 87, no. 3, pages 372 - 6
    - V. BOSWELL SMITH; D. SPINA, CURR. OPINION INVESTIG. DRUGS, (2006), vol. 6, no. 11, pages 1136 - 1141
    - C. KROEGEL; M. FOERSTER, EXP. OPINION INVESTIG. DRUGS, (2007), vol. 16, no. 1, pages 109 - 124
    - B. LIPWORTH, LANCET, (2005), vol. 365, pages 167 - 175
    - Encyclopedia of Pharmaceutical Technology, (1994), vol. 9
    - Encyclopedia of Pharmaceutical Technology, (1989), vol. 2
    - Modern Pharmaceutics, MARCEL DEKKER, pages 427 - 432
    - Modern Pharmaceutics, MARCEL DEKKER
    - Encyclopedia of Pharmaceutical Technology, MARCEL DEKKER, vol. 10, pages 191 - 221
    - TET. LETT., (1995), vol. 36, pages 5319 - 22
    - J. ORG. CHEM., (2000), vol. 65, pages 2847 - 50
    - TET. LETT., (2003), vol. 44, pages 1675 - 78
    - J. ORG. CHEM., (1973), vol. 38, page 1239
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.